Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease

Abstract

Background & Aims The inflammatory bowel diseases (IBD) ulcerative colitis (UC) and Crohn’s disease (CD) cause significant morbidity and are increasing in prevalence among all populations, including African Americans. More than 200 susceptibility loci have been identified in populations of predominantly European ancestry, but few loci have been associated with IBD in other ethnicities. Methods We performed 2 high-density, genome-wide scans comprising 2345 cases of African Americans with IBD (1646 with CD, 583 with UC, and 116 inflammatory bowel disease unclassified [IBD-U]) and 5002 individuals without IBD (controls, identified from the Health Retirement Study and Kaiser Permanente database). Single-nucleotide polymorphisms (SNPs) associated at P<5.0×10−8 in meta-analysis with a nominal evidence (P<.05) in each scan were considered to have genome-wide significance. Results We detected SNPs at HLA-DRB1, and African-specific SNPs at ZNF649 and LSAMP, with associations of genome-wide significance for UC. We detected SNPs at USP25 with associations of genome-wide significance associations for IBD. No associations of genome-wide significance were detected for CD. In addition, 9 genes previously associated with IBD contained SNPs with significant evidence for replication (P<1.6×10−6): ADCY3, CXCR6, HLA-DRB1 to HLA-DQA1 (genome-wide significance on conditioning), IL12B, PTGER4, and TNC for IBD; IL23R, PTGER4, and SNX20 (in strong linkage disequilibrium with NOD2) for CD; and KCNQ2 (near TNFRSF6B) for UC. Several of these genes, such as TNC (near TNFSF15), CXCR6, and genes associated with IBD at the HLA locus, contained SNPs with unique association patterns with African-specific alleles. Conclusions We performed a genome-wide association study of African Americans with IBD and identified loci associated with CD and UC in only this population; we also replicated loci identified in European populations. The detection of variants associated with IBD risk in only people of African descent demonstrates the importance of studying the genetics of IBD and other complex diseases in populations beyond those of European ancestry.

Genetic and Transcriptomic Variation Linked to Neutrophil Granulocyte–Macrophage Colony-Stimulating Factor Signaling in Pediatric Crohn’s Disease

“…11,12 Clinical and demographic features are summarized in Supplementary Table 1. Genomic DNA was extracted from whole blood from 567 early-onset (age 0-18 years) IBD samples; 543 (95.8%) of these samples passed DNA quality control.…”

Genetics: Clues in the code

“…NOD2 variants seem to have little involvement in Japanese and Korean people with Crohn's disease, for instance. And a study of more than 2,300 African Americans with IBD found 2 genetic markers linked to ulcerative colitis that have not been seen in people of European ancestry 4 . The European chips have complicated efforts to identify the genes that are most important in various ethnic groups.…”

Minority Pediatric Patients with Inflammatory Bowel Disease Demonstrate an Increased Length of Stay

“…While emerging literature suggests that the genetic determinants of IBD may differ by race 1 leading to differences in disease presentation, these biological factors may be further modified by disparities in care delivery. Despite the fact that black patients are suspected to have an overall lower prevalence of IBD in the US, prior studies have suggested that black patients are more likely to experience IBD-related hospitalizations and higher IBD-related mortality when compared to non-Hispanic white and Hispanic populations.…”